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ABSTRACT  Angiotensinogen  was  synthesized  by  cells  derived  from  the  Reuber  H35  rat 
hepatoma.  Independent clones  produced  similar amounts of angiotensinogen,  which corre- 
sponded  to about four times  more than expected  for normal  hepatocytes.  The protein was 
secreted  rapidly  but  could  be  visualized  within  cells  using  immunofluorescence.  For  one 
clone,  it is shown that maximal  angiotensinogen  synthesis  occurred  during mid-exponential 
growth.  Somatic  cell  genetics  techniques  have  been  used  to  investigate  the  regulation  of 
angiotensinogen  expression.  Eleven  clones  of  dedifferentiated  variant  hepatoma  cells  that 
failed to produce most or all of the liver specific  proteins analyzed including albumin fell into 
two groups: Seven clones produced only 1-3% as much angiotensinogen as the differentiated 
clones, and four showed a reduction to 10-30%. Clones of the latter class were the only ones 
among  the  eleven  analyzed  that  retained  the  potential  to  give  rise  to  revertants,  showing 
restoration of the differentiated  state. All revertants fully restored angiotensinogen production, 
but only some of them re-expressed albumin.  Somatic hybrids between differentiated  hepa- 
toma cells and one of the variants  showed a substantial  reduction in angiotensinogen produc- 
tion,  whereas for some clones,  albumin  synthesis  was fully  maintained.  These  results  show 
that regulation of the expression of angiotensinogen and of a second serum protein, albumin, 
was independent  and that angiotensinogen  synthesis  was a faithful  indicator of the general 
differentiation  profile of all classes of clones. 
Angiotensinogen, a glycoprotein secreted by the liver (1), is 
the substrate of renin, which cleaves angiotensinogen to re- 
lease  a  decapeptide angiotensin  I.  Angiotensin  I  is  further 
hydrolyzed by converting enzyme to produce the octapeptide 
angiotensin II, the biologically active molecule that plays an 
important role in the regulation of blood pressure. 
Angiotensinogen is a key element in the dynamics of the 
renin-angiotensin system since its concentration in plasma is 
a  limiting factor in the reaction (2).  Some information has 
been obtained concerning the site of synthesis and hormonal 
regulation of  angiotensinogen production using liver (1), liver 
slices (3, 4), or isolated rat hepatocytes (5). However, the lack 
of  a well-defined culture system ofangiotensinogen-producing 
cells has, until now, been a serious hindrance to understanding 
the regulation of angiotensinogen synthesis. 
We have observed that cell lines of Reuber H35 hepatoma 
produced large  amounts  of angiotensinogen that  could be 
measured using direct radioimmunoassay (RIA) 1 and visual- 
ized within  the cells,  using immunofluorescence. We have 
compared the rates of angiotensinogen and albumin synthesis 
in several independent clonal lines of this hepatoma and, in 
particular, we have established the culture cycle variations in 
the secretion of both proteins for one of the clones. 
A second series of experiments was undertaken to examine 
the regulation of angiotensinogen expression, and to deter- 
mine whether its expression could be dissociated from that of 
other liver-specific  functions, particularly, albumin synthesis. 
For this study, we took advantage of two experimental situa- 
Abbreviations used in this paper:.  G-, glucose-free  (i.e., containing 
<10 ug/glucose; G  ÷, containing 10 mM glucose; RIA, radioimmu- 
noassay. 
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blocked,  apparently at the transcriptional level,  and  subse- 
quently restored (6, 7). This occurs first in a series of dediffer- 
entiated variant clones, some of which give rise to revertants 
that again produce albumin. Second, some clones of somatic 
hybrids between albumin-negative variants and the differen- 
tiated  cells  of origin  show extinction  of expression  of the 
albumin gene  and  its re-expression subsequent to  chromo- 
some loss. 
MATERIALS  AND  METHODS 
Culture Conditions:  Cells  were  grown  at  37"C  on  Falcon  plastic 
(Petri  dishes or flasks; Falcon  Labware,  Oxnard,  CA) in  modified  (8) F12 
medium (9) in a humidified  incubator  flushed with 7% CO2 in air. Standard 
medium was supplemented  with  5%  fetal calf serum (Gibeo  Laboratories, 
Grand Island, NY), whereas the selective glucose-free medium (G-) was su~ 
plemented  with 5% extensively dialyzed fetal calf serum (containing < 10 ug/ 
ml of glucose) and 2 mM oxaloacetate (10). G ÷ medium differs from G- only 
in that it contains  10 mM glucose. For transfer, cells were detached in a saline 
solution containing trypsin and EDTA (0.5 and 0.2 g/liter, respectively). 
Cell Lines:  All cell lines used were descendants of the Reuber H35 (11) 
rat hepatoma clone H4IIEC3 of PiLot et al. (12). H5 is a spontaneous dediffer- 
entiated variant that was isolated directly from H4IIECS, whereas p4 and C2, 
two other spontaneous dedifferentiated clones, were isolated from subciones of 
H411EC3 (13). The other variants were obtained from mutagen-treated cells of 
Fao, a differentiated subclone of H41IECS, by using G- medium in conjunction 
with the bromodeoxyuridine-visible  fight suicide technique  (14). HF hybrid 
clones  result  from the  fusion  between  H5  variant  cells and  those  of well 
differentiated Fao cells (15). 
Reversion  Test of Dedifferentiated Cell Lines:  The potential 
of variant cells to revert to the differentiated  state was tested by selecting for 
re-expression of the gluconeogenic enzymes (10), and detected by challenging 
cultures of variant cells in G- medium. Cells were first adapted to growth in 
dialyzed serum in G ÷ medium, grown to confluence (2-5 x  l& cells/cm2), and 
switched to G- medium.  Such cultures showed signs of degeneration after 2--4 
d, and most cells had detached within a week. Survivors in G- were obtained 
from only some of the dedifferentiated variant clones, despite the fact that 5 x 
10s-10 t° cells of each clone had been challenged in selective medium (16, 14). 
Cultures  for the Assay  of Serum Proteins:  For all  cell lines, 
serum protein secretion was measured at the beginning of the stationary phase, 
as follows: 10-cm petri dishes were inoculated with 2 x  105 cells and renewed 
with fresh medium regularly, until the cultures approached  confluence; at that 
time and 24 h later, cells of two dishes were detached, counted,  and the 24-h 
spent  medium was collected for assay of angiotensinogen  and albumin.  For 
Fao cells, secretion was evaluated during the growth cycle: 10-cm petri dishes 
were inoculated  with 2 x  105 cells and,  after  24 h, cells of two dishes were 
detached, counted,  and collected for protein determination.  At the same time 
the remaining dishes were renewed with fresh medium and at regular intervals 
(24 or 48 h, depending on the growth phase examined), the medium of at least 
two dishes was collected for albumin (values previously published in  17) and 
angiotensinogen assays, while the cells were detached, counted,  and harvested 
for protein determination.  The amount of, protein secreted was expressed per 
106 cells/24 h or per milligram total protein/24  h, taking into account  for the 
increase in cell number or in protein  content during the interval of secretion 
(17). 
Immunocytochemical  Staining of Intracellular  Angioten- 
sinogen and Albumin:  To  reveal  intracellular  angiotensinogen  and 
albumin,  indirect immunofluorescent  staining was carried out on cells grown 
on glass cover slips. For details of this staining, see reference 18. Briefly, after 
fixation cells were incubated  with rabbit antiserum directed against either rat 
albumin (diluted  1:100) or rat angiotensinogen (diluted  1:50), and the bound 
immunoglobulins  were detected by further incubation  with sheep fluorescein- 
conjugated globulin, directed against rabbit IgG (Pasteur Institute Production, 
Pards, France). For albumin, M~vel-Ninio and Weiss (18) have determined that 
the sensitivity of the staining is such that >50% of the cells are clearly positive 
in a population  characterized by the secretion of only 50 ng albumin/24 h/10  6 
cells. The secretion rates of  albumin and angiotensinogen for most of  the clones 
used here were ~50- and flvefold greater, respectively, than these threshold 
values. Assuming a similar sensitivity of staining for each protein, it could be 
anticipated  that intracellular  angiotensinogen  would be clearly revealed, but 
with an intensity weaker than that observed for albumin. 
Angiotensinogen Assay:  Anglotensinogen  was measured by direct 
RIA as described  previously  (19). Pure  angiotensinogen  was prepared  from 
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plasma of  bilaterally nephrectomized rats (20). Antibodies directed against pure 
rat angiotensinogen  were those  previously described  (19), and a  dilution  of 
1:60,000 bound 50% of ~2~I-angiotensinogen  (5,000 cpm). They were specific 
for rat anglotensinogen and did not cross-react with angiotensinogen of other 
species, in particular with angiotensinogen of fetal calf serum that was present 
in the culture medium. Angiotensinogen was cleaved by renin to angiotensin I 
(not  recognized  by  antiangiotensinogen  antibodies)  and  des-angiotensin  l- 
angiotensinogen; The latter cross-reacted with the antibodies, as well as with 
the entire molecule. Even if renin from calf serum could cleave the angioten- 
sinogen secreted by cells, the  measurements would  not have been  affected. 
(Note that indirect RIA based on the measure of angiotensin I would be totally 
inappropriate: Antibodies directed against angiotensin I recognized the peptide 
of all species, including that generated from the bovine serum used in culture 
medium.) 
Direct RIA permits the detection  of as few as 5 ng/ml of angiotensinogen. 
In some cases the spent medium was concentrated  10-30-fold. We verified that 
no angiotensinogen was present in similarly concentrated  virgin medium.  To 
evaluate the amount of intracellular  angiotensinogen,  cells were lysed in  10 
mM phosphate buffer, pH 7.5, containing  1% sodium deoxycholate. The lysate 
was clarified by centrifugation and the superuatant was collected for assay. 
Albumin Assay:  Albumin secreted  into spent  culture  medium was 
measured  using the electroimmunodiffusion  technique  according  to LaureU 
(21), as detailed in 17. When necessary, spent medium was concentrated up to 
200-fold  on  Centriflo  membranes (Amicon  Corp.,  Scientific Systems  Div., 
Danvers, MA). No reactive material  was detected in virgin medium that was 
concentrated  up to 250-fold. The rabbit antiserum permitted  the detection  of 
0.1 ug/ml of albumin. 
Protein Assay:  The cells were rinsed twice with cold phosphate buffer, 
counted, and centrifuged. The cell pellet (1-5 x  10  ~  cells) was dissolved in 0.5- 
2.0 ml of 1 N NaOH, and the protein content was determined according to the 
procedure of  Lowry et al. (22). Bovine serum albumin (Armour  Pharmaceutical 
Co., Tarrytown, NY) was used as standard. 
RESULTS 
Demonstration of Angiotensinogen Production by 
Rat Hepatoma Cells in Culture 
The origins of the cloned cell lines used in this work are 
indicated in the genealogical chart (Fig.  1). All the cell lines 
on the left have been characterized as "well differentiated" 
on the basis of morphology, albumin synthesis, the activity of 
six  enzymes characteristic of hepatocyte differentiation (ty- 
rosine and  alanine aminotransferases, the liver-specific  iso- 
zymes of aldolase and alcohol dehydrogenase, and the gluco- 
neogenic enzymes fructose 1-6 diphosphatase and phosphoen- 
olpyruvate carboxykinase), and the inducibility by glucocor- 
ticosteroid hormones of the two aminotransferases. The pre- 
fix,  2s  indicates  that  the  cell  line  contains twice  as  many 
chromosomes as  the  others.  (The  other  cell  lines  will  be 
considered below.) 
Table I gives the results of measuring angiotensinogen and 
albumin on spent culture medium for six independent clones, 
two of which are 2s.  The  cells of each  secreted significant 
amounts of angiotensinogen, ~250 ng/106 cells/24 h, except 
for 2s cells, which produced approximately twice this amount. 
The same cells secreted about ten times more albumin than 
angiotensinogen. Weigand et al. (5) have measured these two 
proteins produced by suspensions of freshly isolated hepato- 
cytes  and  used  these  data  to  calculate  synthesis  rates  for 
angiotensinogen and albumin by liver cells in situ (Table I). 
The immunological identity to purified rat angiotensinogen 
of the  material  measured  in  culture  medium  was demon- 
strated by the fact that parallel lines were obtained when a 
series of dilutions of both sources of antigen was measured 
using direct RIA (Fig.  2).  The secretion of angiotensinogen 
into culture medium was a linear function of time for at least 
36 h  (data not presented). Angiotensinogen was synthesized 
by the cells and secreted rapidly:  4.6 ng of intracellular angi- Differentiated  clones  Variants 
of origin  class I  class  I[ 
Revertants 
H4II  -  H5 
Fu 5-5  ~- p 4 
Faza 967 
1' 
Fao 
2 s Faza ~ 
2  s Fou  4 
5 
5 
5 
5 
C2  •  C2  Rev 
3A  = 3A  Rev 
5  K-----~5  K  Rev 
50  ------~  50  Rev  c/ 
C 
L 
K-4 
0  1 
FIGURE  1  Genealogical chart  of cell  lines.  On  the  left,  the well 
differentiated series of clones, all ultimately derived from the Reu- 
ber H35 clonal line H411EC3 of Pitot et al. (12), abbreviated here as 
H411. Cells of these lines all express the seven liver-specific functions 
we routinely study (13, 16). In the middle of the figure is the variant 
dedifferentiated clones.  Cells of these lines fail to express all (or 
most) of the seven liver-specific functions. They were either isolated 
as  subclones  of altered morphology (lines designated  by a  letter, 
H5, p4, and C2; [13]) or isolated selectively following mutagenesis 
of Fao cells  (lines designated with  a  number,  i.e., 3A;  [14]).  The 
variants comprise two classes,  defined  by their ability to give rise 
to revertants able to proliferate in G-  medium  (see Materials and 
Methods). Clones of class I fail to give rise to revertants (frequency 
<5 x  10  -9 to 10-10); those of class  II do give rise to revertants, and 
at frequencies ranging from  10  -4 to 10  -a. Revertants of C2 and 3A 
are treated  here; those of 5K and 50  (dotted arrows)  have been 
isolated but are not considered further. 
TABLE  I 
Secretion of Angiotensinogen and Albumin by Independent Rat 
Hepatoma Clones 
Angioten-  AIbumin/Angio- 
Clone  sinogen  Albumin  tensinogen 
nanograms/106  cells~24 h* 
H411  185  2,400  13 
Fu5-5  260  600  t  2 
Faza 967  260  2,600  10 
Fao  250  2,500  10 
2s Faza  580  5,300  9 
2s Fou  565  8,000  14 
Rat liver in situ  t  65  48,000  740 
* Data obtained from cultures at the end of the exponential or the beginning 
of the stationary phase (see Fig. 3). 
t Fu5-5 populations are heterogeneous  for albumin production. Some cells 
produce only very small amounts (7), and this accounts for the low albumin 
production rate and the low ratio of albumin to angiotensinogen  in spent 
culture medium. 
s Values calculated from the results of Weigand et al. (5). 
otensinogen was found per 106 Fao cells, which corresponded 
to the amount secreted in  25-30 min. A  similar calculated 
secretion time for albumin by Fao cells has been reported (6, 
17), and direct pulse chase experiments (23) on other clones 
of the same hepatoma have demonstrated that, for albumin, 
secretion rates are a direct reflection of synthesis rates. It is 
very likely that the same holds for angiotensinogen. 
com 
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FIGURE  2  Angiotensinogen radioimmunoassay. Standard curve of 
rat angiotensinogen (@), and dilutions of spent medium from an Fao 
culture (4,). 
Measurements of secreted and intracellular angiotensino- 
gen represent only an average for a given cell population. It 
was  therefore  desirable  to  ascertain  whether  all  cells  of a 
population were actively engaged in the synthesis of angioten- 
sinogen. Fig. 3 a shows the image obtained using immunoflu- 
orescence when Fao cells were treated to reveal intracellular 
angiotensinogen.  (Fig.  3 c shows cells of a  line that secreted 
only marginal amounts of angiotensinogen, which was used 
as a control.) For comparison, Fig. 3 b shows the intracellular 
albumin of Fao cells. Whether stained for angiotensinogen or 
albumin, the great majority of Fao cells showed fluorescence 
in the region of the Golgi apparatus, and, as anticipated, the 
fluorescence was less  brilliant  for angiotensinogen than  for 
albumin. In addition, the homogeneity of fluorescence in the 
individual cells indicates that the respective rates of synthesis 
and secretion of each protein were approximately the same 
for all cells in the population. 
Angiotensinogen production was not constant during the 
course of the growth cycle. In our initial survey of  the different 
clones, higher values than given in Table l were obtained for 
some  samples  from  exponential-phase  culture  (data  not 
shown). The relationship between stage of growth cycle and 
production  of angiotensinogen  was determined throughout 
the growth cycle of Fao cells. The results are shown in Fig. 4. 
When  expressed  per cell,  angiotensinogen  production  was 
constant during the late exponential and stationary phases, 
with a sharp peak in mid-exponential phase (when there are 
2.8  x  l0  4 cells/cm2).  If angiotensinogen  production  is ex- 
pressed per milligram cell protein, the mid-exponential peak 
was followed by a slow and continuous decline (Fig. 4 b), due 
to the increase in cellular protein content during stationary 
phase. In Fig. 4 we have also plotted the results of albumin 
measurements on the same medium samples. Albumin syn- 
thesis followed a different pattern during the growth cycle of 
Fao cells,  and its maximal secretion was situated at the end 
of the exponential phase (1.2  ×  l0  5 cells/cm2).  Modulations 
BOUHNIK ET AL.  Angiotensinogen  Production by Rat Hepatoma  Cells  551 FIGURE  3  Immunofluorescence staining of angiotensinogen and of albumin in rat hepatoma cells. The photomicrographs show: 
left, phase-contrast  images, right,  immunofluorescent staining;  (a) Fao cells, stained for angiotensinogen; (b) Fao cells, stained for 
albumin; (c) p4 cells, stained for angiotensinogen, x  750. 
in the synthesis rates of the two proteins thus occurred inde- 
pendently  during  the  course  of the  growth  cycle  of these 
hepatoma cells. 
Somatic Cell Genetic Analysis: Hepatoma 
Variants 
Descendants of the Reuber H35  hepatoma line H4II are 
extremely stable  in  their  differentiation:  Among the  seven 
liver-specific functions  cited  above that  we  have  routinely 
studied, quantitative but not qualitative interclonal variations 
have been observed (13). Nevertheless, it has been possible to 
isolate "variant" subclones whose cells failed to produce most 
or all of the liver-specific proteins. Such variants are so rare 
that it not possible to assign a frequency to their appearance. 
They have been detected as subclones of altered morphology 
("spontaneous" variants,  an example of which is shown in 
Fig. 3 c), or isolated selectively after mutagenesis (see Materials 
and  Methods).  The  variant clones  can  be  assigned  to  two 
classes as indicated in Fig.  1: those referred to as Class I failed 
to give rise to revertants (see below), and those of Class II did 
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so but at very low frequency (11,  16, and unpublished results). 
The cells of both classes were nearly or totally deficient in the 
production of albumin (Table II). 
When  we considered the  characterization  for angiotensi- 
nogen production, we encountered a situation different from 
that observed for albumin synthesis. Whereas all of the eleven 
variant clones analyzed showed a reduction in angiotensino- 
gen synthesis, two groups of clones could be distinguished 
(Table  II).  Cells  of seven  clones  produced  only  traces  of 
angiotensinogen, corresponding to 1-3% as much of the pro- 
tein  as the  differentiated cells of origin.  However, those of 
four clones showed only a  modest reduction, to  10-30% of 
the parental value. The genealogical chart (Fig.  1) reveals that 
the  four  clones  that  retained  the  highest  angiotensinogen 
production  are  the  four  previously  shown  to  give  rise  to 
revertants and that the  seven very low producers are those 
that did not. Note that two clones of class I were derived from 
clones of class II (Fig.  1 and Table II) and that even for these, 
this distinction holds. Until now, angiotensinogen production 
was the only function found to correlate positively with the 
potential of variant to revert to the differentiated state.  o-214 
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FIGURE 4  Secretion  of  angiotensinogen  by  Fao  cells  during the 
growth cycle. In a, the amounts of protein secreted are expressed 
per  cell,  whereas  in  b  they  are  presented  as  a  function  of  cell 
protein. The production of albumin (dashed lines, and inner ordi- 
nate scale) is shown for comparison. Symbols used: O, angiotensi- 
nogen; O, albumin; ~-, cell number; and x, protein per cell. 
TABLE  II 
Secretion of Angiotensinogen and Albumin by Dedifferentiated 
Variant Rat Hepatoma Cells 
Clone  Angiotensinogen  Albumin 
nanograms/106  % of  nanograms/106  % of 
cells~24  h  parental*  cells~24  h  parental 
Class I 
H5  6  3  <0.5  <0.02 
p4  3  1  <3  <0.5 
4C  4  2  <2  <0.1 
5C  3  1  <3  <0.1 
5 L  4  2  <2  <0.1 
5K-4  t  3  1  <4  <0.2 
50-1*  4  2  <2  <0.1 
Classll 
C2  30-70  12-28  <1;24  ~  <0.1;1 t 
3A  30-95  12-37  <3  <0.1 
5K  25  10  25  1 
50  35  14  20  1 
* Calculated from the closest  ~differentiated" parent as indicated in Fig. 1. 
t Subclones derived from 5K and 50 (See Class II). The derivation of Class I 
clones from Class II clones is a rare event, but it does occur (14). 
! The only c~tures of C2 cells that produce traces of albumin are those that 
have  been  maintained  at confluence for several  days;  All cultures tested 
produce angiotensinogen. 
Revertants 
The test for reversion of variants back to the differentiated 
state was carried out by challenging large numbers of cells in 
G-  medium: Under these conditions, the only cells able to 
survive and form colonies were those that produced the liver- 
specific gluconeogenic enzymes. Although selective pressure 
was exerted only for re-expression of two enzymes, the ma- 
jority of revertants analyzed so far showed re-expression of 
the entire group of liver-specific functions ([16]; Cassio, man- 
uscript in preparation). 
We considered revertant clones derived from C2  and 3A 
cells.  For all eight clones included in Table III, there was a 
significant  increase  in  angiotensinogen  synthesis,  which 
ranged  from  two  to  six  times  higher  than  the  maximal 
amounts recorded for C2 and 3A cells, and from about half 
to nearly double the amounts measured for the well differen- 
tiated clones of origin (Table I). Selection for re-expression of 
the gluconeogenic enzymes thus resulted in re-establishment 
of angiotensinogen synthesis rates characteristic of the well- 
differentiated hepatoma cells. Considering that we are dealing 
with revertants of two different variant clones, and with three 
independent revertant clones in each case, the range of values 
found for angiotensinogen production was very narrow. This 
is particulary striking when compared with the re-expression 
of albumin  production  (Table  III).  In  these  revertants,  we 
found both a  qualitative and a  quantitative dissociation in 
the expression of the two serum proteins. Two of the three 
revertants of 3A cells synthesized no albumin at all, but they 
did  produce  angiotensinogen.  An  example  of quantitative 
dissociation of the expression of these functions was found in 
the case of two subclones of C2Revl cells: For both, large and 
approximately equal amounts of angiotensinogen were pro- 
duced, whereas one was very active in albumin synthesis and 
the other produced 20-fold less. 
Hepatoma Cell Hybrids 
Somatic hybrids formed by the fusion of variant hepatoma 
cells  with  the  well-differentiated  cells  of origin  provide  a 
means  of investigating  the  change  that  led  to  the  loss  of 
differentiation  of the  variant  cells.  In general,  it  has been 
found that hybrids of this type fail to express the functions of 
the differentiated parent,  leading to two conclusions: First, 
TABLE III 
Angiotensinogen and Albumin Secreted by Revertants of C2 
and 3A Cells 
Clone  Angiotensinogen  Albumin 
nanograms/lO  6  nanograms/106 
cells~24 h  cells~24 h 
Differentiated  parent 
Fao  250  2,500 
Variants 
3A  30-95  <3 
C2  30-70  <1 ;24 
Revertants 
3A Revl  205  <1 
3A RevC  190  <3 
3A RevE  220  200 
C2 Revb  100  140 
C2 Rev7  280  600 
C2 Revl  430  4,150 
C2 Revl-1  410  140 
C2 Revl-4  390  3,050 
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consequence of the absence of some factor necessary to main- 
tain  the  differentiated  state,  and  second,  the  variant  cells 
produce factors acting in trans that inhibit the expression of 
a functional genome (15). 
Hybrids between Fao  cells and  variant H5  cells contain 
essentially one full complement of chromosomes from each 
parent (15). They show extinction of the expression of most, 
but not all,  of the functions of the Fao parent. All of the six 
hybrid clones analyzed for angiotensinogen showed a signifi- 
cant  reduction  in  the  synthesis of this  protein  (Table  IV). 
Cells of two clones continued to produce about one-quarter 
as much  as the  Fao  parent,  whereas the  others were even 
lower:  two  were  reduced  to  the  H5  level.  These  same six 
hybrid clones gave very different results when analyzed for 
albumin: Expression of this function was hardly affected in 
some clones and, at the other extreme, was totally abolished 
in others. However, if the clones were ordered according to 
decreasing expression of one function, the same order held 
for the other (Table IV). Whereas the values recorded indicate 
that the synthesis of angiotensinogen was more sensitive than 
that of albumin to the extinguishing effect of the H5 parent, 
a  similar pattern  of expression  of the  two  serum  proteins 
emerged when the entire group of clones was considered. 
The extinction of angiotensinogen expression in these hy- 
brid cells was not due to an irreversible change. Cells of  hybrid 
clone HF1 were challenged in G- medium; survivors obtained 
at a frequency of 10  -7 had undergone significant chromosome 
loss (35%;  [15]).  One clone of this group, HF1-5, was tested 
for angiotensinogen and found to be one of the most active 
of all the clones studied  in  synthesis of this protein (Table 
IV). 
DISCUSSION 
The  results presented  here provide clear evidence that  the 
factors regulating angiotensinogen and albumin production 
are different. If regulation of the expression of two or more 
genes occurs via a  common  mechanism,  it  should  not  be 
possible to  dissociate  the  synthesis  of their  products.  This 
reasoning can be applied to two levels of gene expression: 
quantitative  modulations  in  the  amounts  of gene product, 
and the decision of whether the gene is expressed at all.  At 
TABLE  IV 
Angiotensinogen and Albumin Secretion by Somatic Hybrids 
H5 x  Fao* 
Clone  Angiotensinogen  Albumin 
nanograms/lO  6  % of  nanograms/10  °  % of 
cells~24 h  parental  cells~24  h  parental 
Parents 
Fao  250  (100)  2,500  (100) 
H5  6  --  <0.5  -- 
Hybrids 
HF6  58  23  2,880  115 
HF5  54  22  1,870  75 
HF3  28  11  1,250  50 
H F4  16  6  740  30 
HF8  4  2  <9  <0.4 
HF1  4  2  <4  <0.2 
HF1-5  560  224  6,250  250 
* All  hybrid clones  contain near to the expected number of chromosomes 
for a ls x  ls hybrid (52 +  52) except HF1-5 (69 chromosomes). 
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both  levels we  observed dissociation  in  the  production  of 
angiotensinogen and albumin by Reuber H35 rat hepatoma 
cells in culture. 
Quantitative  modulations  in  the  production  of secreted 
proteins are particularly amenable to analysis because secre- 
tion rates can be equated to synthesis rates (23),  and, in the 
case of albumin, secretion rates are also a direct reflection of 
the intraceUular concentration of albumin mRNA (6). During 
the growth cycle of Fao cells, the secretion of angiotensinogen 
and of albumin was not constant, and the maximal produc- 
tion of each protein was observed at a different time. Immu- 
nofluorescence analysis showed that both proteins are synthe- 
sized by most cells. It can therefore be concluded that mod- 
ulations in the synthesis rates of the two proteins most likely 
reflected independent mechanisms. The somatic hybrids de- 
scribed here present a second instance of independent mod- 
ulations in the secretion rates of the two proteins. 
Differences as to whether or not synthesize angiotensinogen 
and albumin have been encountered in the study of hepatoma 
cell variants and their revertants. In several cases, cells totally 
deficient  in  albumin  production  (and  in  albumin  mRNA; 
[6]) have been found to produce significant amounts of an- 
giotensinogen; the reverse has not been observed. 
In an earlier study concerning the expression of a-fetopro- 
tein and albumin by mouse hepatoma x  rat hepatoma hybrid 
cells, we observed coordination in the synthesis of mouse a- 
fetoprotein,  mouse  albumin,  and  rat  albumin  (18).  It  re- 
mained  to  be determined  whether  a  pattern  of coordinate 
expression could  pertain  to other serum proteins normally 
synthesized  by hepatocytes.  The  present  results  show that 
angiotensinogen synthesis was regulated differently from al- 
bumin and, therefore by extrapolation, from AFP as well.  It 
is perhaps significant in this context to recall that albumin 
and AFP show extensive structural homology (24,  25),  that 
the  corresponding genes  present  homology at  the  level  of 
domains  (26,  27),  and  that  they  are  closely linked  in  the 
mouse  (28).  Although  these  two  genes  are  most certainly 
derived from a  common ancestor,  there is no information 
concerning a possible ancestor gene of angiotensinogen. 
Angiotensinogen  synthesis correlates extremely well  with 
the general differentiation profile of Reuber hepatoma cells. 
Each  of the  well-differentiated  clones  of origin  showed  a 
similar production rate; Each of the variant clones was char- 
acterized by a reduced rate, and the extent of the reduction is 
directly correlated with the retention or loss of the potential 
of the  variant cells to revert to the differentiated state.  All 
revertants analyzed showed full restoration of angiotensino- 
gen synthesis. By contrast, albumin synthesis was unexpect- 
edly low or even absent in some of the revertants, and the 
same holds for some of the hepatic enzymes analyzed (16). 
To our knowledge, this is the first report ofangiotensinogen 
synthesis  by  cells  in  continuous  culture.  Surprisingly,  the 
Reuber hepatoma cells  produced more of the protein than 
normal  hepatocytes. Weigand  et at.  (5)  have  reported that 
freshly isolated rat hepatocytes produce 24 ng/106  cells/24 h 
of angiotensinogen, and calculated that this represents about 
one-third of the rate anticipated for normal liver in situ. The 
cell lines used here produced 250-500  ng/106  cells/24 h  of 
the protein. By contrast, they synthesized markedly less al- 
bumin than normal liver cells. 
The availability of permanent cell  lines active in the syn- 
thesis of a  serum  protein known  to play a  key role in  the 
physiology and the  pathology of the  organism should  find numerous applications.  One aspect of the regulation of angi- 
otensinogen production that has not been considered here is 
the effect of hormones. Numerous factors that increase angi- 
otensinogen concentration in the plasma have been identified, 
including glucocorticoids (29),  thyroid hormones (30),  estro- 
gens (31, 32), and angiotensin II (33). The mode of action of 
these  factors  has  been  impossible  to  define  owing  to  the 
absence of a well-defined culture system. This analysis is now 
possible. 
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